Electromed, Inc. (ELMD)
- Previous Close
15.72 - Open
15.73 - Bid 11.50 x 2900
- Ask 18.50 x 1000
- Day's Range
15.58 - 16.49 - 52 Week Range
8.80 - 17.85 - Volume
66,067 - Avg. Volume
32,669 - Market Cap (intraday)
141.04M - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
36.42 - EPS (TTM)
0.45 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
smartvest.comRecent News: ELMD
Performance Overview: ELMD
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELMD
Valuation Measures
Market Cap
135.27M
Enterprise Value
124.84M
Trailing P/E
34.93
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.66
Price/Book (mrq)
3.35
Enterprise Value/Revenue
2.42
Enterprise Value/EBITDA
21.48
Financial Highlights
Profitability and Income Statement
Profit Margin
7.62%
Return on Assets (ttm)
7.21%
Return on Equity (ttm)
10.40%
Revenue (ttm)
51.69M
Net Income Avi to Common (ttm)
3.94M
Diluted EPS (ttm)
0.45
Balance Sheet and Cash Flow
Total Cash (mrq)
10.43M
Total Debt/Equity (mrq)
0.31%
Levered Free Cash Flow (ttm)
2.78M